Results 1 to 10 of about 88,192 (248)

Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil. [PDF]

PLoS ONE, 2013
OBJECTIVE: To identify the incidence of and risk factors for tuberculosis in people living with HIV (PLHIV). DESIGN: Observational, prospective cohort study. METHODS: A total of 2069 HIV-infected patients was observed between July 2007 and December 2010.
Joanna d'Arc Lyra Batista, Maria de Fátima Pessoa Militão de Albuquerque, Magda Maruza, Ricardo Arraes de Alencar Ximenes, Marcela Lopes Santos, Ulisses Ramos Montarroyos, Demócrito de Barros Miranda-Filho, Heloisa Ramos Lacerda, Laura Cunha Rodrigues   +8 more
doaj   +5 more sources

Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans [PDF]

, 2014
Very little is known about the growth and mutation rates of Mycobacterium tuberculosis during latent infection in humans. However, studies in rhesus macaques have suggested that latent infections have mutation rates that are higher than that observed ...
Alland, David, Arcus, Vickery L., Colangeli, Roberto, Coley, Kathy, Cursons, Raymond T., Karalus, Noel, Kim, Soyeon, Manning, Shannon D., Marchiano, Emily, Ruthe, Ali   +9 more
core   +35 more sources

Using Electronic Health Record Data to Measure the Latent Tuberculosis Infection Care Cascade in Safety-Net Primary Care Clinics

AJPM Focus, 2023
Introduction: Prevention of tuberculosis disease through diagnosis and treatment of latent tuberculosis infection is critical for achieving tuberculosis elimination in the U.S.
Laura A. Vonnahme, MPH, Julia Raykin, PhD, Matthew Jones, MS, Jee Oakley, MPH, Jon Puro, MPA, Adam Langer, DVM, Kaylynn Aiona, MPH, Robert Belknap, MD, Tracy Ayers, PhD, Jonathan Todd, PhD, Kathryn Winglee, PhD   +10 more
doaj   +1 more source

Latent Tuberculosis Infection in Potential Renal Transplant Recipients and Live Donors in a Tertiary Level Transplant Center in Nepal

Journal of Nobel Medical College, 2022
Background: Active tuberculosis in transplant recipients can result from latent infection with Mycobacterium Tuberculosis in the transplant recipients, donor tissue, or de novo post-transplant infection.
Suresh Maharjan, Bikash Khatri, Deepa Chemjong, Bijay Khatri, Dibya Singh Shah   +4 more
doaj   +1 more source

Treatment of Latent Tuberculosis Infection [PDF]

Current Treatment Options in Infectious Diseases, 2017
The treatment of latent tuberculosis infection (LTBI) is an essential component of tuberculosis (TB) elimination in regions that have a low incidence of TB. However, the decision to treat individuals with LTBI must consider the limitations of current diagnostic tests for LTBI, the risk of developing active TB disease, the potential adverse effects from
Tang, Patrick, Johnston, James
openaire   +4 more sources

Possibilities of Detecting an Epidemic Focus of Tuberculosis Infection in an Indicator Patient with a Positive Immunological Test for Tuberculosis

Эпидемиология и вакцинопрофилактика, 2023
Relevance. In connection with the advent of new diagnostic immunological tests, it became possible to determine a potential focus of infection not only through the identification of patients with tuberculosis, but also through the identification of ...
G. S. Oganezova, E. M. Bogorodskaya, N. I. Briko, E. M. Belilovsky   +3 more
doaj   +1 more source

Determination of Urinary Neopterin/Creatinine Ratio to Distinguish Active Tuberculosis from Latent Mycobacterium tuberculosis Infection. [PDF]

, 2016
BACKGROUND: Biomarkers to distinguish latent from active Mycobacterium (M.) tuberculosis infection in clinical practice are lacking. The urinary neopterin/creatinine ratio can quantify the systemic interferon-gamma effect in patients with M. tuberculosis
Eisenhut, M, Hargreaves, DS, Housley, D, Mulla, R, Scott, A, Walters, A   +5 more
core   +7 more sources

Acceptance and influencing factors of preventive treatment for latent tuberculosis infection: a review

Zhongguo gonggong weisheng, 2023
Preventive treatment for latent tuberculosis infection is one of the key measures to achieve the goal of ending tuberculosis. Currently, the acceptance of preventive treatment among different populations is unclear.
Yemin YUAN, Shixue LI, Chengchao ZHOU
doaj   +1 more source

Changes in the rate of bacillus tuberculosis infection in health workers in the first year of the COVID-19 epidemic in Kashan- Iran

Heliyon, 2023
Objective: This cohort study aimed to determine the prevalence and risk factors of latent tuberculosis infection among healthcare workers during the COVID-19 pandemic.
Mojgan Sehat, Reza Razzaghi, Mark Ghamsary, Monireh Faghir Ganji, Mojtaba Sehat   +4 more
doaj   +1 more source

Treatment of latent tuberculosis infection [PDF]

Therapeutic Advances in Respiratory Disease, 2013
Treatment of latent tuberculosis (TB) infection is an important component of TB control programs in both high- and low-prevalence countries. Clinical trials of treatment of latent TB conducted over several decades have demonstrated that preventive treatment can reduce the risk of developing active TB up to 90%.
Madhavi J. Parekh, Neil W. Schluger
openaire   +5 more sources